WR Wealth Planners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$5.9K Sell
16
-6
-27% -$2.51K ﹤0.01% 669
2024
Q3
$11.4K Sell
22
-7
-24% -$3.74K ﹤0.01% 602
2024
Q2
$15.7K Buy
29
+12
+71% +$6.34K ﹤0.01% 487
2024
Q1
$8.81K Buy
+17
New +$8.46K ﹤0.01% 619
2023
Q4
Sell
-68
Closed -$29.6K 379
2023
Q3
$29.6K Hold
68
0.01% 380
2023
Q2
$30.2K Buy
68
+33
+94% +$15.2K 0.01% 382
2023
Q1
$16.1K Buy
+35
New +$16.7K 0.01% 455

Other funds holding ELV

WR Wealth Planners's ELV Position: Q4 2024 in Review

WR Wealth Planners reduced its Elevance Health (ELV) stake by 27% in Q4 2024, selling an estimated $2.51K and leaving 16 shares worth $5.9K. The position accounts for ﹤0.01% of the portfolio, ranked #669.

WR Wealth Planners first reported a position in ELV in Q1 2023 and has held it in 7 quarters since. The position peaked at $30.2K in Q2 2023. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • WR Wealth Planners held 16 shares of Elevance Health worth $5.9K as of Q4 2024.
  • WR Wealth Planners sold 6 Elevance Health shares in Q4 2024, an estimated $2.51K.
  • Elevance Health made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #669 holding.
  • WR Wealth Planners first reported a position in Elevance Health in Q1 2023 and has held it in 7 quarters since.
  • WR Wealth Planners's Elevance Health position peaked at $30.2K in Q2 2023.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.